Camber Capital Management LP - Q1 2019 holdings

$2.01 Billion is the total value of Camber Capital Management LP's 28 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 0.0% .

 Value Shares↓ Weighting
ALXN  ALEXION PHARMACEUTICALS INC$81,108,000
+38.8%
600,0000.0%4.04%
+45.8%
NKTR  NEKTAR THERAPEUTICS$67,200,000
+2.2%
2,000,0000.0%3.35%
+7.3%
MNTA  MOMENTA PHARMACEUTICALS INC$58,120,000
+31.6%
4,000,0000.0%2.90%
+38.2%
THOR  SYNTHORX INC$37,931,000
+17.2%
1,862,1160.0%1.89%
+23.1%
ZYME  ZYMEWORKS INC$35,046,000
+10.2%
2,166,0000.0%1.75%
+15.8%
AMAG  AMAG PHARMACEUTICALS INC$34,132,000
-15.2%
2,650,0000.0%1.70%
-10.9%
EGRX  EAGLE PHARMACEUTICALS INC$14,723,000
+25.3%
291,6000.0%0.73%
+31.8%
STRO  SUTRO BIOPHARMA INC$6,834,000
+26.3%
600,0000.0%0.34%
+32.7%
SGRY  SURGERY PARTNERS INC$1,806,000
+15.3%
160,0840.0%0.09%
+21.6%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TEVA PHARMACEUTICALS INDS LTD34Q3 20239.7%
BROOKDALE SR LIVING INC32Q3 20235.0%
PERRIGO CO PLC29Q3 20237.1%
TENET HEALTHCARE CORP28Q3 20238.5%
NEKTAR THERAPEUTICS28Q1 20229.8%
UNIVERSAL HLTH SVCS INC25Q3 20239.9%
MYRIAD GENETICS INC24Q3 20235.0%
SAREPTA THERAPEUTICS INC23Q3 20236.0%
MYLAN NV21Q3 202010.1%
AMAG PHARMACEUTICALS INC21Q3 20204.0%

View Camber Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)

View Camber Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
SC 13G2023-10-30
13F-HR2023-08-14

View Camber Capital Management LP's complete filings history.

Compare quarters

Export Camber Capital Management LP's holdings